AHSCT Combined With CAR-T Cells in the Treatment of Refractory and Relapsed Multiple Myeloma
Status:
Recruiting
Trial end date:
2025-03-01
Target enrollment:
Participant gender:
Summary
Clinical Study on the Safety and Effectiveness of Autologous Hematopoietic Stem Cell
Transplantation Combined With CAR-T Cells in the Treatment of Refractory and Relapsed
Multiple Myeloma